Table of Content

1 INTRODUCTION (Page No. - 31)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
          TABLE 1 INCLUSIONS AND EXCLUSIONS
    1.3 STUDY SCOPE 
           1.3.1 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
          TABLE 2 USD EXCHANGE RATES
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
    1.7 LIMITATIONS 
2 RESEARCH METHODOLOGY (Page No. - 36)
    2.1 RESEARCH DATA 
          FIGURE 1 FETAL MONITORING MARKET: RESEARCH DESIGN METHODOLOGY
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    TABLE 3 KEY DATA FROM PRIMARY SOURCES
                    FIGURE 3 KEY INDUSTRY INSIGHTS
                    FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                    FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,  AND REGION
    2.2 MARKET SIZE ESTIMATION 
           2.2.1 BOTTOM-UP APPROACH
                    FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
                    FIGURE 7 APPROACH 3: PARENT MARKET ANALYSIS (ULTRASOUND MARKET)
                    2.2.1.1 Growth forecast
                                FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
                                FIGURE 9 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ANALYSIS 
    2.5 STUDY ASSUMPTIONS 
    2.6 RISK ASSESSMENT 
    2.7 IMPACT OF RECESSION 
3 EXECUTIVE SUMMARY (Page No. - 48)
    FIGURE 11 FETAL MONITORING MARKET, BY PRODUCT, 2022 VS. 2027 (USD BILLION)
    FIGURE 12 FETAL MONITORING MARKET, BY PORTABILITY, 2022 VS. 2027 (USD BILLION)
    FIGURE 13 FETAL MONITORING MARKET, BY METHOD, 2022 VS. 2027 (USD BILLION)
    FIGURE 14 FETAL MONITORING MARKET, BY APPLICATION, 2022 VS. 2027 (USD BILLION)
    FIGURE 15 FETAL MONITORING MARKET, BY END USER, 2022 VS. 2027 (USD BILLION)
    FIGURE 16 REGIONAL SNAPSHOT OF FETAL MONITORING MARKET
4 PREMIUM INSIGHTS (Page No. - 52)
    4.1 FETAL MONITORING MARKET OVERVIEW 
          FIGURE 17 RISING PRETERM BIRTHS TO DRIVE FETAL MONITORING MARKET
    4.2 ASIA PACIFIC: FETAL MONITORING MARKET, BY METHOD (2021) 
          FIGURE 18 NON-INVASIVE METHODS ACCOUNTED FOR LARGEST SHARE IN 2021
    4.3 REGIONAL GROWTH OPPORTUNITIES IN FETAL MONITORING MARKET 
          FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.4 FETAL MONITORING MARKET: REGIONAL MIX 
          FIGURE 20 ASIA PACIFIC MARKET TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD
    4.5 FETAL MONITORING MARKET: DEVELOPED VS. DEVELOPING ECONOMIES 
          FIGURE 21 DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 56)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 22 FETAL MONITORING MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Rising number of preterm births and increasing adoption of infertility treatment
                    5.2.1.2 Advanced and innovative fetal monitoring technologies
                    5.2.1.3 Government initiatives and increasing collaborations for research by health agencies
                    5.2.1.4 Reimbursement and insurance policies for fetal monitoring services
                                TABLE 4 CPT CODES FOR VAGINAL DELIVERIES
                    5.2.1.5 Active product launches by key manufacturers
                    5.2.1.6 Increasing number of obstetrics and gynecology centers for fetal monitoring
           5.2.2 RESTRAINTS
                    5.2.2.1 High costs of fetal monitoring equipment
                    5.2.2.2 Availability of refurbished products
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Development of non-invasive, portable, and advanced fetal monitors
                    5.2.3.2 Emerging markets and strengthening infrastructure
           5.2.4 CHALLENGES
                    5.2.4.1 Product recalls
                                TABLE 5 PRODUCT RECALLS IN FETAL MONITORING MARKET
                    5.2.4.2 Lack of skilled healthcare professionals
    5.3 SUPPLY CHAIN ANALYSIS 
          FIGURE 23 DIRECT DISTRIBUTION – PREFERRED STRATEGY OF PROMINENT COMPANIES
    5.4 VALUE CHAIN ANALYSIS 
          FIGURE 24 FETAL MONITORING MARKET: VALUE CHAIN ANALYSIS
    5.5 ECOSYSTEM ANALYSIS 
          FIGURE 25 FETAL MONITORING MARKET: ECOSYSTEM ANALYSIS
           5.5.1 ROLE IN ECOSYSTEM
                    FIGURE 26 KEY PLAYERS IN FETAL MONITORING MARKET ECOSYSTEM
    5.6 REGULATORY LANDSCAPE 
          TABLE 6 REGULATORY AUTHORITIES
           5.6.1 EU REGULATIONS
           5.6.2 US REGULATIONS
    5.7 PORTER'S FIVE FORCES ANALYSIS 
           5.7.1 THREAT FROM NEW ENTRANTS
           5.7.2 BARGAINING POWER OF SUPPLIERS
           5.7.3 BARGAINING POWER OF BUYERS
           5.7.4 INTENSITY OF COMPETITIVE RIVALRY
           5.7.5 THREAT OF SUBSTITUTES
    5.8 PATENT ANALYSIS OF FETAL MONITORING PRODUCTS 
          FIGURE 27 PATENT ANALYSIS: UTERINE CONTRACTION MONITORS  (2013–NOVEMBER 2022)
          FIGURE 28 PATENT ANALYSIS: FETAL DOPPLERS (2013–NOVEMBER 2022)
          FIGURE 29 PATENT ANALYSIS: FETAL ELECTRODES (2013–NOVEMBER 2022)
    5.9 TRADE ANALYSIS FOR ULTRASOUND 
           5.9.1 IMPORT DATA FOR ULTRASOUND, BY COUNTRY,  2017–2021 (USD MILLION)
           5.9.2 EXPORT DATA FOR ULTRASOUND, BY COUNTRY,  2017–2021 (USD MILLION)
    5.10 TECHNOLOGY ANALYSIS 
           TABLE 7 AVERAGE SELLING PRICE OF FETAL MONITORING PRODUCTS
6 FETAL MONITORING MARKET, BY PRODUCT (Page No. - 76)
    6.1 INTRODUCTION 
          TABLE 8 FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
    6.2 ULTRASOUND DEVICES 
          TABLE 9 ULTRASOUND DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 10 ULTRASOUND DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.2.1 2D ULTRASOUND
                    6.2.1.1 Increasing commercialization of innovative 2D technologies
                                TABLE 11 2D ULTRASOUND: FETAL MONITORING MARKET, BY REGION,  2020–2027 (USD MILLION)
           6.2.2 3D & 4D ULTRASOUND
                    6.2.2.1 Technological advantages of 3D & 4D ultrasound over 2D ultrasound
                                TABLE 12 3D & 4D ULTRASOUND: FETAL MONITORING MARKET, BY REGION,  2020–2027 (USD MILLION)
           6.2.3 DOPPLER IMAGING
                    6.2.3.1 Doppler imaging vital to analyze hemodynamics in fetal surveillance
                                TABLE 13 DOPPLER IMAGING: FETAL MONITORING MARKET, BY REGION,  2020–2027 (USD MILLION)
    6.3 ELECTRONIC MATERNAL/FETAL MONITORS 
           6.3.1 RISING NUMBER OF HIGH-RISK PREGNANCIES
                    TABLE 14 ELECTRONIC MATERNAL/FETAL MONITORS MARKET, BY REGION,  2020–2027 (USD MILLION)
    6.4 FETAL ELECTRODES 
           6.4.1 NEED FOR INTRAPARTUM FETAL SURVEILLANCE
                    TABLE 15 FETAL ELECTRODES MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.5 FETAL DOPPLER DEVICES 
           6.5.1 INCREASING USE OF FETAL DOPPLERS IN-HOME CARE SETTINGS
                    TABLE 16 FETAL DOPPLER DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.6 UTERINE CONTRACTION MONITORS 
          TABLE 17 UTERINE CONTRACTION MONITORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 18 UTERINE CONTRACTION MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.6.1 INTERNAL UTERINE CONTRACTION MONITORS
                    6.6.1.1 Accurate measurements obtained by internal UCMs
                                TABLE 19 INTERNAL UTERINE CONTRACTION MONITORS MARKET, BY REGION,  2020–2027 (USD MILLION)
           6.6.2 EXTERNAL UTERINE CONTRACTION MONITORS
                    6.6.2.1 Developments underway to overcome drawbacks of external UCMs
                                TABLE 20 EXTERNAL UTERINE CONTRACTION MONITORS MARKET, BY REGION,  2020–2027 (USD MILLION)
    6.7 TELEMETRY DEVICES 
           6.7.1 REMOTE MONITORING INCORPORATED INTO TELEMETRY DEVICES
                    TABLE 21 TELEMETRY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.8 ACCESSORIES & CONSUMABLES 
           6.8.1 ADVANCEMENTS IN FETAL MONITORING TO LEAD TO INCREASING UTILIZATION OF ACCESSORIES & CONSUMABLES
                    TABLE 22 ACCESSORIES & CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.9 OTHER PRODUCTS 
          TABLE 23 OTHER PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION)
7 FETAL MONITORING MARKET, BY PORTABILITY (Page No. - 89)
    7.1 INTRODUCTION 
          TABLE 24 FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
    7.2 NON-PORTABLE SYSTEMS 
           7.2.1 TECHNOLOGICAL ADVANCEMENTS IN NON-PORTABLE SYSTEMS TO SUPPORT MARKET GROWTH
                    TABLE 25 NON-PORTABLE SYSTEMS: FETAL MONITORING MARKET, BY REGION,  2020–2027 (USD MILLION)
    7.3 PORTABLE SYSTEMS 
           7.3.1 REMOTE ACCURACY OFFERED BY PORTABLE SYSTEMS TO DRIVE MARKET GROWTH
                    TABLE 26 PORTABLE SYSTEMS: FETAL MONITORING MARKET, BY REGION,  2020–2027 (USD MILLION)
8 FETAL MONITORING MARKET, BY METHOD (Page No. - 93)
    8.1 INTRODUCTION 
          TABLE 27 FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
    8.2 NON-INVASIVE METHOD 
           8.2.1 NON-INVASIVE METHODS WIDELY ADOPTED IN HIGH-RISK PREGNANCIES
                    TABLE 28 NON-INVASIVE FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
    8.3 INVASIVE METHOD 
           8.3.1 CONSISTENT TRANSMISSION OF FETAL HEART RATE POSSIBLE VIA INVASIVE METHODS
                    TABLE 29 INVASIVE FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
9 FETAL MONITORING MARKET, BY APPLICATION (Page No. - 97)
    9.1 INTRODUCTION 
          TABLE 30 FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    9.2 ANTEPARTUM 
           9.2.1 INCREASING INCIDENCES OF PREGNANCY-RELATED COMPLICATIONS TO SUPPORT GROWTH
                    TABLE 31 ANTEPARTUM FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
    9.3 INTRAPARTUM 
           9.3.1 FAVORABLE GUIDELINES BY HEALTHCARE AUTHORITIES TO PROPEL GROWTH
                    TABLE 32 INTRAPARTUM FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
10 FETAL MONITORING MARKET, BY END USER (Page No. - 101)
     10.1 INTRODUCTION 
             TABLE 33 FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.2 HOSPITALS 
             10.2.1 AVAILABILITY OF WELL-ESTABLISHED HEALTHCARE INFRASTRUCTURE TO DRIVE SEGMENT GROWTH
                       TABLE 34 HOSPITALS: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
     10.3 OBSTETRICS & GYNECOLOGY CLINICS 
             10.3.1 RISING EMPHASIS ON PERINATAL CARE TO BOLSTER GROWTH OF SEGMENT
                       TABLE 35 OBSTETRICS & GYNECOLOGY CLINICS: FETAL MONITORING MARKET, BY REGION,  2020–2027 (USD MILLION)
     10.4 HOME CARE SETTINGS 
             10.4.1 REMOTE CARE BY PORTABLE FETAL MONITORING SYSTEMS TO DRIVE GROWTH
                       TABLE 36 HOME CARE SETTINGS: FETAL MONITORING MARKET, BY REGION,  2020–2027 (USD MILLION)
11 FETAL MONITORING MARKET, BY REGION (Page No. - 106)
     11.1 INTRODUCTION 
             TABLE 37 FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
     11.2 NORTH AMERICA 
             FIGURE 30 NORTH AMERICA: FETAL MONITORING MARKET SNAPSHOT
             TABLE 38 NORTH AMERICA: FETAL MONITORING MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
             TABLE 39 NORTH AMERICA: FETAL MONITORING MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
             TABLE 40 NORTH AMERICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
             TABLE 41 NORTH AMERICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 42 NORTH AMERICA: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
             TABLE 43 NORTH AMERICA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
             TABLE 44 NORTH AMERICA: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
             TABLE 45 NORTH AMERICA: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.2.1 RECESSION IMPACT
             11.2.2 US
                        11.2.2.1 US held largest share of North American market in 2021
                                      FIGURE 31 US: PRETERM BIRTH RATE, BY RACE/ETHNICITY, 2018–2020 (AVERAGE)
                                      TABLE 46 ULTRASOUND CPT CODES
                                      TABLE 47 US: FETAL MONITORING MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                                      TABLE 48 US: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 49 US: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 50 US: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                                      TABLE 51 US: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 52 US: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                      TABLE 53 US: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.2.3 CANADA
                        11.2.3.1 Growing government initiatives for fetal and maternal care to drive market growth in Canada
                                      FIGURE 32 CANADA: NUMBER OF BIRTHS, 2011 TO 2021
                                      TABLE 54 CANADA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 55 CANADA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 56 CANADA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 57 CANADA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
                                      TABLE 58 CANADA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 59 CANADA: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                      TABLE 60 CANADA: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
     11.3 EUROPE 
             TABLE 61 EUROPE: FETAL MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 62 EUROPE: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 63 EUROPE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
             TABLE 64 EUROPE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS,  BY TYPE, 2020–2027 (USD MILLION)
             TABLE 65 EUROPE: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
             TABLE 66 EUROPE: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
             TABLE 67 EUROPE: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
             TABLE 68 EUROPE: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.3.1 RECESSION IMPACT
             11.3.2 GERMANY
                        11.3.2.1 Increasing healthcare expenditure to support market growth in Germany
                                      TABLE 69 GERMANY: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 70 GERMANY: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 71 GERMANY: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 72 GERMANY: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                                      TABLE 73 GERMANY: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 74 GERMANY: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                      TABLE 75 GERMANY: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.3.3 UK
                        11.3.3.1 Rising emphasis on better maternity services to drive market growth in UK
                                      TABLE 76 UK: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 77 UK: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 78 UK: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 79 UK: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                                      TABLE 80 UK: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 81 UK: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 82 UK: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.4 FRANCE
                        11.3.4.1 Increasing focus on healthcare policies to accelerate market growth in France
                                      TABLE 83 FRANCE: HEALTHCARE SPENDING, 2011–2019
                                      TABLE 84 FRANCE: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 85 FRANCE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 86 FRANCE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 87 FRANCE: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
                                      TABLE 88 FRANCE: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 89 FRANCE: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 90 FRANCE: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.5 ITALY
                        11.3.5.1 Increasing healthcare expenditure to propel growth of market in Italy
                                      TABLE 91 ITALY: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 92 ITALY: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 93 ITALY: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 94 ITALY: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
                                      TABLE 95 ITALY: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 96 ITALY: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 97 ITALY: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.6 SPAIN
                        11.3.6.1 Declining birth rate to restrain growth of market in Spain
                                      TABLE 98 SPAIN: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 99 SPAIN: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 100 SPAIN: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 101 SPAIN: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
                                      TABLE 102 SPAIN: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 103 SPAIN: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 104 SPAIN: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.7 REST OF EUROPE
                       TABLE 105 REST OF EUROPE: FETAL MONITORING MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                       TABLE 106 REST OF EUROPE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 107 REST OF EUROPE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 108 REST OF EUROPE: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                       TABLE 109 REST OF EUROPE: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                       TABLE 110 REST OF EUROPE: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                       TABLE 111 REST OF EUROPE: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
     11.4 ASIA PACIFIC 
            FIGURE 33 ASIA PACIFIC: FETAL MONITORING MARKET SNAPSHOT
             11.4.1 RECESSION IMPACT
                       TABLE 112 ASIA PACIFIC: FETAL MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                       TABLE 113 ASIA PACIFIC: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                       TABLE 114 ASIA PACIFIC: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 115 ASIA PACIFIC: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS,  BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 116 ASIA PACIFIC: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                       TABLE 117 ASIA PACIFIC: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                       TABLE 118 ASIA PACIFIC: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                       TABLE 119 ASIA PACIFIC: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.4.2 JAPAN
                        11.4.2.1 Increasing focus on launch of innovative products to propel market growth in Japan
                                      TABLE 120 JAPAN: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 121 JAPAN: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE,  2020–2027 (USD MILLION)
                                      TABLE 122 JAPAN: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 123 JAPAN: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
                                      TABLE 124 JAPAN: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 125 JAPAN: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 126 JAPAN: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.3 CHINA
                        11.4.3.1 Developing healthcare infrastructure in China to support market growth
                                      TABLE 127 CHINA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 128 CHINA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 129 CHINA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 130 CHINA: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                                      TABLE 131 CHINA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 132 CHINA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 133 CHINA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.4 INDIA
                        11.4.4.1 Growing number of preterm births to drive market growth in India
                                      TABLE 134 INDIA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 135 INDIA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 136 INDIA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 137 INDIA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
                                      TABLE 138 INDIA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 139 INDIA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 140 INDIA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.5 SOUTH KOREA
                        11.4.5.1 Increasing implementation of ultrasound technology to drive market in South Korea
                                      TABLE 141 SOUTH KOREA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 142 SOUTH KOREA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 143 SOUTH KOREA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 144 SOUTH KOREA: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                                      TABLE 145 SOUTH KOREA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 146 SOUTH KOREA: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                      TABLE 147 SOUTH KOREA: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.4.6 AUSTRALIA
                        11.4.6.1 Rising emphasis on maternal care to bolster market growth in Australia
                                      TABLE 148 AUSTRALIA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 149 AUSTRALIA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 150 AUSTRALIA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 151 AUSTRALIA: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                                      TABLE 152 AUSTRALIA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 153 AUSTRALIA: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                      TABLE 154 AUSTRALIA: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.4.7 REST OF ASIA PACIFIC
                       TABLE 155 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                       TABLE 156 REST OF ASIA PACIFIC: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 157 REST OF ASIA PACIFIC: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 158 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                       TABLE 159 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY METHOD,  2020–2027 (USD MILLION)
                       TABLE 160 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                       TABLE 161 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
     11.5 REST OF THE WORLD 
             11.5.1 RECESSION IMPACT
                       TABLE 162 REST OF THE WORLD: FETAL MONITORING MARKET, BY REGION,  2020–2027 (USD MILLION)
                       TABLE 163 REST OF THE WORLD: FETAL MONITORING MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                       TABLE 164 REST OF THE WORLD: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 165 REST OF THE WORLD: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 166 REST OF THE WORLD: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                       TABLE 167 REST OF THE WORLD: FETAL MONITORING MARKET, BY METHOD,  2020–2027 (USD MILLION)
                       TABLE 168 REST OF THE WORLD: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                       TABLE 169 REST OF THE WORLD: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.5.2 LATIN AMERICA
                        11.5.2.1 Favorable government policies to support growth of market
                                      TABLE 170 LATIN AMERICA: FETAL MONITORING MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                                      TABLE 171 LATIN AMERICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 172 LATIN AMERICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 173 LATIN AMERICA: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                                      TABLE 174 LATIN AMERICA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 175 LATIN AMERICA: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                      TABLE 176 LATIN AMERICA: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.5.3 MIDDLE EAST & AFRICA
                        11.5.3.1 High number of pre-term births recorded to boost market
                                      TABLE 177 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                                      TABLE 178 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 179 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 180 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                                      TABLE 181 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY METHOD,  2020–2027 (USD MILLION)
                                      TABLE 182 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                      TABLE 183 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
12 COMPETITIVE LANDSCAPE (Page No. - 177)
     12.1 OVERVIEW 
     12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
             TABLE 184 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES
     12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 
             FIGURE 34 REVENUE SHARE ANALYSIS OF TOP PLAYERS
     12.4 MARKET SHARE ANALYSIS 
             FIGURE 35 FETAL MONITORING MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
     12.5 COMPANY EVALUATION QUADRANT (2021) 
             12.5.1 STARS
             12.5.2 EMERGING LEADERS
             12.5.3 PERVASIVE PLAYERS
             12.5.4 PARTICIPANTS
                        FIGURE 36 FETAL MONITORING MARKET: COMPANY EVALUATION QUADRANT, 2021
     12.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2021) 
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 STARTING BLOCKS
             12.6.3 RESPONSIVE COMPANIES
             12.6.4 DYNAMIC COMPANIES
                        FIGURE 37 FETAL MONITORING MARKET: START-UP/SME EVALUATION QUADRANT, 2021
     12.7 COMPETITIVE BENCHMARKING 
             TABLE 185 FETAL MONITORING MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
             TABLE 186 PRODUCT FOOTPRINT OF KEY PLAYERS
             TABLE 187 REGIONAL FOOTPRINT OF KEY PLAYERS
     12.8 COMPETITIVE SCENARIO 
             12.8.1 PRODUCT LAUNCHES
                         TABLE 188 PRODUCT LAUNCHES, 2019–NOVEMBER 2022
             12.8.2 DEALS
                         TABLE 189 DEALS, 2019–NOVEMBER 2022
             12.8.3 OTHER DEVELOPMENTS
                         TABLE 190 OTHER DEVELOPMENTS, 2019–NOVEMBER 2022
13 COMPANY PROFILES (Page No. - 190)
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
     13.1 KEY PLAYERS 
             13.1.1 GE HEALTHCARE
                         TABLE 191 GE HEALTHCARE: BUSINESS OVERVIEW
                         FIGURE 38 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
                         TABLE 192 GE HEALTHCARE: PRODUCTS OFFERED
                         TABLE 193 GE HEALTHCARE: DEALS
             13.1.2 SIEMENS HEALTHINEERS
                         TABLE 194 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
                         FIGURE 39 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
                         TABLE 195 SIEMENS HEALTHINEERS: PRODUCTS OFFERED
                         TABLE 196 SIEMENS HEALTHINEERS: DEALS
             13.1.3 CARDINAL HEALTH, INC.
                         TABLE 197 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
                         FIGURE 40 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT
                         TABLE 198 CARDINAL HEALTH, INC.: PRODUCTS OFFERED
             13.1.4 KONINKLIJKE PHILIPS N.V.
                         TABLE 199 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
                         FIGURE 41 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
                         TABLE 200 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
                         TABLE 201 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES
             13.1.5 FUJIFILM SONOSITE, INC.
                         TABLE 202 FUJIFILM SONOSITE, INC.: BUSINESS OVERVIEW
                         FIGURE 42 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
                         TABLE 203 FUJIFILM SONOSITE, INC.: PRODUCTS OFFERED
                         TABLE 204 FUJIFILM SONOSITE, INC.: PRODUCT LAUNCHES
                         TABLE 205 FUJIFILM SONOSITE, INC.: DEALS
             13.1.6 HUNTLEIGH HEALTHCARE LIMITED
                         TABLE 206 HUNTLEIGH HEALTHCARE LIMITED: BUSINESS OVERVIEW
                         FIGURE 43 ARJO: COMPANY SNAPSHOT
                         TABLE 207 HUNTLEIGH HEALTHCARE LIMITED: PRODUCTS OFFERED
             13.1.7 NATUS MEDICAL INCORPORATED
                         TABLE 208 NATUS MEDICAL INCORPORATED: BUSINESS OVERVIEW
                         FIGURE 44 NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
                         TABLE 209 NATUS MEDICAL INCORPORATED: PRODUCTS OFFERED
                         TABLE 210 NATUS MEDICAL INCORPORATED: DEALS
             13.1.8 THE COOPER COMPANIES, INC.
                         TABLE 211 THE COOPER COMPANIES, INC.: BUSINESS OVERVIEW
                         FIGURE 45 THE COOPER COMPANIES, INC.: COMPANY SNAPSHOT
                         TABLE 212 THE COOPER COMPANIES, INC.: PRODUCTS OFFERED
                         TABLE 213 THE COOPER COMPANIES, INC.: DEALS
             13.1.9 CONTEC MEDICAL SYSTEMS CO., LTD.
                         TABLE 214 CONTEC MEDICAL SYSTEMS CO., LTD.: BUSINESS OVERVIEW
                         TABLE 215 CONTEC MEDICAL SYSTEMS CO., LTD.: PRODUCTS OFFERED
                         TABLE 216 CONTEC MEDICAL SYSTEMS CO., LTD.: PRODUCT LAUNCHES
                         TABLE 217 CONTEC MEDICAL SYSTEMS CO., LTD.: DEALS
             13.1.10 EDAN INSTRUMENTS, INC.
                         TABLE 218 EDAN INSTRUMENTS, INC.: BUSINESS OVERVIEW
                         TABLE 219 EDAN INSTRUMENTS, INC.: PRODUCTS OFFERED
                         TABLE 220 EDAN INSTRUMENTS, INC.: DEALS
                         TABLE 221 EDAN INSTRUMENTS, INC.: OTHER DEVELOPMENTS
     13.2 OTHER PLAYERS 
             13.2.1 NEOVENTA MEDICAL AB
             13.2.2 BIONET CO., LTD.
             13.2.3 PROGETTI SRL
             13.2.4 TRISMED CO., LTD.
             13.2.5 SHENZHEN LUCKCOME TECHNOLOGY INC., LTD.
             13.2.6 MEDGYN PRODUCTS, INC.
             13.2.7 DIXION
             13.2.8 PROMED TECHNOLOGY CO., LTD.
             13.2.9 ADVANCED INSTRUMENTATIONS
             13.2.10 BRAEL-MEDICAL EQUIPMENT
             13.2.11 GPC MEDICAL LTD.
             13.2.12 SHENZHEN VCOMIN TECHNOLOGY LIMITED
             13.2.13 BISTOS CO., LTD.
             13.2.14 MEDIANA CO., LTD.
             13.2.15 LIFE PLUS HEALTHCARE (P) LTD.
             13.2.16 CHOICEMMED
             13.2.17 TRIVITRON HEALTHCARE
             13.2.18 DOTT MEDICAL CO. LTD.
             13.2.19 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.
             13.2.20 NEMO HEALTHCARE
             13.2.21 MINDCHILD MEDICAL, INC.
             13.2.22 MELODY INTERNATIONAL LTD.
             13.2.23 JANITRI INNOVATIONS PVT. LTD.
             13.2.24 LAERDAL GLOBAL HEALTH
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
14 APPENDIX (Page No. - 238)
     14.1 INDUSTRY INSIGHTS 
     14.2 DISCUSSION GUIDE 
     14.3 KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL 
     14.4 CUSTOMIZATION OPTIONS 
     14.5 RELATED REPORTS 
     14.6 AUTHOR DETAILS